Company Filing History:
Years Active: 2017
Title: Innovations of Jingang Zheng in Abdominal Aortic Aneurysm Treatment
Introduction
Jingang Zheng is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the treatment of abdominal aortic aneurysms. His innovative approach utilizes naringenin, a compound that shows promise in preventing and treating this serious condition.
Latest Patents
Jingang Zheng holds a patent for the "Use of naringenin in preparing drugs for preventing and/or treatment abdominal aortic aneurysm." This patent highlights the potential of naringenin in developing products aimed at preventing and treating abdominal aortic aneurysms. The research involved testing the efficacy of naringenin in two clinically associated disease models, demonstrating its ability to significantly inhibit the onset and development of abdominal aortic aneurysms in mice.
Career Highlights
Zheng's career is marked by his dedication to research and innovation in the medical field. His work at Peking University has positioned him as a leading figure in the study of abdominal aortic aneurysms. His research findings have the potential to impact patient care significantly.
Collaborations
Jingang Zheng has collaborated with esteemed colleagues such as Wei Kong and Qinghua Cui. These partnerships have enhanced the depth and breadth of his research, contributing to the advancement of medical knowledge in this area.
Conclusion
Jingang Zheng's innovative work in utilizing naringenin for the treatment of abdominal aortic aneurysms showcases his commitment to improving patient outcomes. His contributions to medical research are invaluable and highlight the importance of innovation in healthcare.